In middle-aged and older men, individual INSL3 values correlate with and predict morbidity (16), in part because they reflect the capacity of the testes to produce androgens, with low INSL3 (<0.4 ng/ml) being a good index for clinical hypogonadism (17). This evidence concerns the gene INSL3 and hypogonadism.